Group One Trading’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,100
Closed -$42K 5714
2019
Q1
$42K Sell
9,100
-13,200
-59% -$62.5K ﹤0.01% 3656
2018
Q4
$78K Sell
22,300
-37,100
-62% -$258K ﹤0.01% 3322
2018
Q3
$599K Sell
59,400
-65,100
-52% -$519K ﹤0.01% 2143
2018
Q2
$901K Buy
124,500
+93,500
+302% +$652K 0.01% 1822
2018
Q1
$187K Buy
31,000
+19,900
+179% +$164K ﹤0.01% 2849
2017
Q4
$107K Sell
11,100
-2,400
-18% -$15.7K ﹤0.01% 3322
2017
Q3
$120K Sell
13,500
-6,000
-31% -$61.9K ﹤0.01% 3117
2017
Q2
$247K Sell
19,500
-48,600
-71% -$575K ﹤0.01% 2487
2017
Q1
$716K Buy
68,100
+59,400
+683% +$633K 0.01% 1586
2016
Q4
$80K Buy
8,700
+4,800
+123% +$54.2K ﹤0.01% 2980
2016
Q3
$46K Buy
3,900
+1,200
+44% +$18.2K ﹤0.01% 3395
2016
Q2
$35K Sell
2,700
-55,400
-95% -$807K ﹤0.01% 3529
2016
Q1
$929K Buy
58,100
+49,900
+609% +$948K 0.01% 1227
2015
Q4
$235K Sell
8,200
-16,500
-67% -$457K ﹤0.01% 2388
2015
Q3
$703K Sell
24,700
-60,800
-71% -$2.24M 0.01% 1522
2015
Q2
$3.07M Buy
85,500
+85,100
+21,275% +$2.65M 0.04% 516
2015
Q1
$12K Sell
400
-200
-33% -$5.29K ﹤0.01% 4096
2014
Q4
$13K Sell
600
-6,200
-91% -$123K ﹤0.01% 4138
2014
Q3
$132K Buy
6,800
+5,600
+467% +$87.9K ﹤0.01% 2754
2014
Q2
$19K Buy
+1,200
New +$19.4K ﹤0.01% 4204
2014
Q1
Sell
-9,000
Closed -$116K 5781
2013
Q4
$116K Buy
+9,000
New +$125K ﹤0.01% 2900

Other funds holding INSY

Group One Trading's INSY Position: Q2 2019 in Review

Group One Trading sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 11,460 shares — an estimated $53K sold.

Group One Trading first reported a position in INSY in Q4 2013 and held it in 7 quarters. The position peaked at $286K in Q1 2016. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Group One Trading reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Group One Trading sold 11,460 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $53K.
  • Group One Trading first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 7 quarters.
  • Group One Trading's Insys Therapeutics, Inc. position peaked at $286K in Q1 2016.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Group One Trading's 13F filing for Q2 2019, filed 9 Aug 2019.